Berlin reports 21 cases of blood clots in AstraZeneca vaccinated and 7 dead

The medical regulator in Germany announced today that it has received data on 21 cases of unusual blood clots in people recently vaccinated with the drug “AstraZeneca” against Covid-19. An email from the Paul Ehrlich Institute to the Associated Press said that seven people with blood clots died.

The appearance of an unusual form of blood clots in the head prompted several European countries to temporarily stop using AstraZeneca’s anti-coronavirus drug earlier this month.

After an expert examination, the EU health regulator found that the risks of possible side effects should be included in the leaflets with vaccine information. Most EU countries have resumed the AstraZeneca vaccine.

According to the Paul Ehrlich Institute, these 21 cases were registered before March 25, and in 12 of them the blood picture of the patients showed an unusually low level of platelets. Nineteen of the cases were in women aged 20 to 63, and two were in men aged 36 and 57.

During the period studied by the Paul Ehrlich Institute, about 2.27 million first doses of AstraZeneca were delivered to Germany.

The seven-day level of infected in Germany per 100,000 inhabitants today was 129.7 – well above the target 100, which provides for the activation of the so-called. “emergency brake”. Health authorities said yesterday that 17,176 new infections and 90 coronavirus-related deaths were reported.

German Chancellor Angela Merkel has stepped up pressure on the prime ministers of the 16 provinces to adhere to the agreed hardening of coronavirus rules due to the growing number of infected.

–